Source: ForexTV

Zosano Pharma: Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update

FREMONT, Calif., May 14, 2020 (GLOBE NEWSWIRE) - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2020, as well as recent business highlights. "This quarter was marked by a momentous milestone for the company with the FDA acceptance for filing of our New Drug ...The post Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update appeared first on ForexTV.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more